SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MAXXON, INC (MXON.Nasdaq BB) Disposable syringe technology
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bcjt who wrote (77)5/16/1999 12:53:00 AM
From: campe  Read Replies (1) of 105
 
bcjt, good insights on M-P. All these constant delays will either give REAL medical companies a chance to catch up OR reveal nothing exists. IMO, buying a PR firm to hype your product means your product isn't there to hype itself.

I think all should read the thread header once again and compare it to where MXON is today. Almost two years ago (May 28th) MXON had Shares outstanding: 8,353,000, Float: 475,000, and Share price: 5.25 - 5.50. Two years ago, this company signed a letter of intent to acquire an exclusive worldwide license to manufacture and market a patented disposable syringe with automatic needle retraction.

Two years later, are they any closer?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News